chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Within 1 month of vaccine an otherwise healthy 22 yr old female was diagnosed with anti NMDA receptor encephalitis.  She was hospitalized and treated with plasmaphereses (5 sessions) and IV steroids. Discharged on 11/14/21 with no outward signs of improvement as of this reporting.
Vaccinations given approximately 3pm, pt's mother paged at 11:30pm reporting axillary temp of 101 F, lack of muscle tone, not breastfeeding. Pt evaluated at ED, admitted on 9/8/2005 for a septic workup, treated with IV fluids, antibiotics and tylenol.  Discharged 09/11/2005. 1/3/06 -Review of 2-page d/c summary. Final diagnosis as possible bacteremia with secondary diagnoses of fever and poor feeding. Treated with ampicillin and cefotaxime. Blood cultures initially showed gram + cocci in chains and gram + rods. Second culture was negative. 20-page medical record indicated child was more sleepy and was not breastfeeding well after immunizations. Temp of 101.4 axillary was noted. Mom gave Tylenol and took baby to ER
Developed swelling at injection site /and surrounding blanching erythema. BENADRYL 25 mg 1 po. Ice to affected area.
Patient reports that there was no pain at injection site the day of injection. Reports feeling a "crook in the neck" the evening of receiving the vaccine. States he woke up the next morning, 4/14/21 with a very painful L arm, couldn't lift it and no strength.  Left arm is still painful and with reduced strength as of 4/28/2021. States arm is still swollen but has improved. Patient saw his primary care provider (not at our clinic) on 4/23/2021 and was given a shot of Toradol for pain. Patient also kept existing appointments with neurosurgery and pain management for failed back surgery. Neurosurgeon advised it could be nerve injury and that it will heal over time. Told patient that nerve in arm could be in a different location due to his history as a body builder. Patient states arm is better but still painful and weak.
Normal muscle aches for first 2 days, then pain wore off. Woke up 4th morning with intense pain in right foot, making it very difficult to walk. Pain eventually went through both legs and left foot. Pain in foot lasted better part of week. This has subsided now, but upsetting while it lasted. Tylenol helped with pain, but not with flexibility.
Fluid ran half way down the arm; This spontaneous case was reported by a consumer and describes the occurrence of UNDERDOSE (Fluid ran half way down the arm) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Apr-2021, the patient experienced UNDERDOSE (Fluid ran half way down the arm). On 27-Apr-2021, UNDERDOSE (Fluid ran half way down the arm) had resolved.            Concomitant medication was not reported.  Treatment information was not provided.
Per mom's report, this infant started with a high pitched cry, inconsolable for 30 minutes after vaccines. It lasted for about 3 hours. Brought him to the doctor and was given Benadryl and infant Tylenol. No blood work done.
1 day after vaccination developed new HA and nausea 2 days after vaccination developed new SOB, pleuritic chest pain
The day after the 2nd dose of Moderna COVID vaccine developed severe shortness of breath.   Shortness of breath has improved some over the past 3 months, but still is present.  For example, when doing laundry or carrying bucket of water, or sometimes just talking to my patients at work, I get shortness of breath.
RED RAISED LUMP AT INJECTION SITE, HOT AND ITCHY ARM. HEADACHE. CHILLS.
After the first two doses presents ringing in the ears. Tinnitus. when applying the fourth dose with Pfizer the sound in the ears doubled.
patient received vaccine on 11/24/08. The next day he had swelling under eye, but went away. Then the day after that swelling on bridge of nose, then went away. Then today, swelling on forehead.
pt was seen in office on 21AUG93 & recvd vax; pt has reflux (gastoresophageal) & sx inc post DTP & had some vomiting of all fluids;
Case number PHEH2014US005596 is an initial spontaneous report received from a physician on 19 Mar 2014. This report refers to a patient of unknown age and gender. This patient was vaccinated with MENVEO (batch number: unknown) intramuscularly on an undetermined date. It was reported that the refrigerator at an off-site clinic was faulty for over a month causing the vaccine to reach above recommended temperatures. Temperature readings showed that the vaccine may have remained around 48 to 50 degree Fahrenheit (F) for several hours intermittently during the month with a maximum temperature of 57.2 degree F. No adverse event was reported following this administration error.
Three days after the first Moderna vaccine, I experienced tremendous pain in the calf of my right leg. It went away the same day with large doses of ibuprofen. Two days later, the pain began again and lasted for three days. It did not respond to pain relievers. I could hardly use my leg to walk, climb stairs, etc.  It went away after the third day.
Information has been received from a physician concerning a 21 year old female who in 2006 was vaccinated intramuscularly with her first 0.5 ml dose of GARDASIL (lot # unspecified).  On unspecified dates the patient was vaccinated intramuscularly with her second and third 0.5 ml doses of GARDASIL (lot # s unspecified).  It was reported that on unspecified date after receiving all 3 doses, the patient developed "A-typical HPV cells".  On unspecified date a PAP test was performed (no results reported).  Unspecified medical attention was sought.  At the time of this report the patient had not recovered.  No additional information was given.  Additional information has been requested.
Headache; significant muscle aches; joint pain; nausea; fatigue; pain at the injection site; dizziness; fever; vision changes; sleep disturbance; booster; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient.  A 63-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), dose 3 (Lot number: 30155BA) via unspecified route of administration at arm right, on 03Dec2021 11:30 at the age of 63 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Osteoporosis" (unspecified if ongoing), notes: other medical history: Osteoporosis; "acid reflux" (unspecified if ongoing), notes: other medical history: acid reflux; "Known allergies: Sulfa antibiotics" (unspecified if ongoing). The patient took concomitant medications. Past drug history included: Sesame, reaction(s): "Known allergies: Sesame", notes: Known allergies: Sesame. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Prior to the vaccination the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19. Vaccination history included: Bnt162b2 (Dose Number: 2, Lot Number: EN6203), via unspecified route of administration on 27Feb2021, when the patient was 63 years old, for COVID-19 immunization; Bnt162b2 (Dose Number: 1, Lot Number: EM9810), via unspecified route of administration on 06Feb2021, when the patient was 62 years old, for Covid-19 immunization. The following information was reported: IMMUNISATION (non-serious) with onset 03Dec2021 11:30, outcome "unknown", described as "booster"; HEADACHE (non-serious) with onset 04Dec2021 03:00, outcome "recovering", described as "Headache"; MYALGIA (non-serious) with onset 04Dec2021 03:00, outcome "recovering", described as "significant muscle aches"; ARTHRALGIA (non-serious) with onset 04Dec2021 03:00, outcome "recovering", described as "joint pain"; NAUSEA (non-serious) with onset 04Dec2021 03:00, outcome "recovering", described as "nausea"; FATIGUE (non-serious) with onset 04Dec2021 03:00, outcome "recovering", described as "fatigue"; VACCINATION SITE PAIN (non-serious) with onset 04Dec2021 03:00, outcome "recovering", described as "pain at the injection site"; DIZZINESS (non-serious) with onset 04Dec2021 03:00, outcome "recovering", described as "dizziness"; PYREXIA (non-serious) with onset 04Dec2021 03:00, outcome "recovering", described as "fever"; VISUAL IMPAIRMENT (non-serious) with onset 04Dec2021 03:00, outcome "recovering", described as "vision changes"; SLEEP DISORDER (non-serious) with onset 04Dec2021 03:00, outcome "recovering", described as "sleep disturbance". Therapeutic measures were not taken as a result of headache, myalgia, arthralgia, nausea, fatigue, vaccination site pain, dizziness, pyrexia, visual impairment, sleep disorder.  No follow-up attempts are possible. No further information is expected.
Redness, soreness, swelling and itching which last for 1 week.  Applied 1% hydrocortisone topically and ice packs.
My doctor diagnosed me with Shingles on 10Sep21.; Have seen doctor 3 times since beginning of August for pain the anal and virginial area.; Have seen doctor 3 times since beginning of August for pain the anal and virginial area.; hemorrhoids; This is a spontaneous report from a contactable consumer (patient) reported for herself. A 37-year-old non pregnant female patient received bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, solution for injection), dose 2 via an unspecified route of administration, administered in right arm on 23Apr2021 12:00 (at the age of 37-years-old) (Batch/Lot Number: EW0176) as dose 2, single for covid-19 immunisation. Medical history included high blood pressure, seasonal allergies and chronic heartburn. The patient previously experienced known allergies: Penicillin. Concomitant medications included dexlansoprazole (DEXILANT) taken for an unspecified indication, start and stop date were not reported. Patient previously took first dose of BNT162B2 (at the age of 37-years-old) (lot number: ER8734, vaccine location: Left arm) on 02Apr2021 12:00 PM for covid-19 immunisation. The patient stated that her doctor diagnosed her with Shingles on 10Sep2021. She have seen doctor 3 times since beginning of August for pain the anal and virginial area. After reviewing her complaints and attempting to treat for hemorrhoids and discussing with another doctor who recently treated a female patient with the same symptoms who was test for Shingles and tested positive. The patient stated that her personal symptoms onset began the last week in June. The patient received medications for the treatment of the events. The patient did not had prolonged hospitalization for the events. The patient visited physician office and emergency room regarding the treatment for the events. Patient did not receive any other vaccines within 4 weeks to the COVID vaccine. The patient was not tested positive for covid 19 prior to vaccination and had not been tested post vaccination. The outcome of all the events was not recovered.   Follow-up attempts are completed. No further information is expected.
Paralized right diaphragm; One day to the next, she couldn't do 2 minutes in the treadmill; This spontaneous case was reported by a consumer and describes the occurrence of DIAPHRAGMATIC PARALYSIS (Paralized right diaphragm) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthma.   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DIAPHRAGMATIC PARALYSIS (Paralized right diaphragm) (seriousness criterion medically significant) and EXERCISE TOLERANCE DECREASED (One day to the next, she couldn't do 2 minutes in the treadmill). At the time of the report, DIAPHRAGMATIC PARALYSIS (Paralized right diaphragm) and EXERCISE TOLERANCE DECREASED (One day to the next, she couldn't do 2 minutes in the treadmill) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, X-ray: abnormal (abnormal) paralized right diaphragm.         Concomitant product use was not provided by the reporter.  No treatment information was provided.  Company comment: Very limited information regarding the event Diaphragmatic Paralysis has been provided at this time. The event Exercise Tolerance Decreased may rather be a consequence of the paralized right diaphragm than be due to the vaccination product. Further information can be requested.   Reporter did not allow further contact; Sender's Comments: Very limited information regarding the event Diaphragmatic Paralysis has been provided at this time. The event Exercise Tolerance Decreased may rather be a consequence of the paralized right diaphragm than be due to the vaccination product. Further information can be requested.
itchy; Hives; This is a spontaneous report from a contactable consumer or other non healthcare professional (patient). A 31-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: EW0198, Expiry date: unknown), via an unspecified route, administered in Arm Right on 25Jul2021 (at the age of 31-years-old) as DOSE 1, 0.3 ML SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Additional Vaccines Administered on Same Date of the Pfizer Suspect was reported as none. Patient's Medical History including any illness at time of vaccination none. Prior Vaccinations (within 4 weeks) was reported as none and Other Products was reported as no. Patient stated that she got the vaccine on 25Jul2021, her first dose and didn't have any side effects. About four days ago (31Jul2021) she got what looks like hives not under her armpit but part of her armpit and on her left and right hip. She clarified as the left side of her waist. Late afternoon 5:27 (on an unknown date) took a picture and texted her mom. She was wondering if it has been a week was that normal or concerning that she was having a reaction. It has not inhibited. It has just itchy (on an unknown date) and she puts aloe vera (treatment received for the events) on it. It has not caused pain just a little annoying. patient was not visited Emergency Room and Physician Office for the events. The outcome of event urticaria was not recovered and the other event was unknown.  Follow-up attempts are completed. No further information is expected
After administering the zoster vaccine, patient feel uncomfortable the next day and begin to develop rash on 7/21. The blister rash appeared on his back and it is tingling and painful. We advised him to see his doctor right away and his doctor confirmed that it is shingle. Doctor gave him medication to treat it. Today is the 8th day from the time he develop the rash and it is still pain, especially at night that he couldnt sleep.
got a slight increase in body temperature of 101.1; This is a spontaneous report from a contactable consumer reported for a female patient (Wife).  A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: not reported), via an unspecified route of administration on 28Feb2021 as dose 2, single for COVID-19 immunization. The patient medical history included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: not reported) via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization. The patients concomitant medications were not reported. On an unknown date in 2021, patient got a slight increase in body temperature of 101.1 F. The clinical outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Numb face/ still numb from nose to chin (nose is less numb); Face, tongue & inside mouth numb; Face, tongue & inside mouth numb; light headed & dizzy; light headed & dizzy; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A 73-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 08Apr2022 at 17:15 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 73 years intramuscular for covid-19 immunisation. The patient's relevant medical history included: "Breast cancer" (unspecified if ongoing), notes: Anastrozole is post-operative treatment for breast cancer. Concomitant medication(s) included: ANASTROZOLE taken for breast cancer female. Vaccination history included: BNT162b2 (Dose Number: 3, Batch/Lot No: FC3180), administration date: 11Oct2021, when the patient was 72-year-old, for COVID-19 immunization; BNT162b2 (Dose Number: 2, Batch/Lot No: EN6207), administration date: 23Mar2021, when the patient was 72-year-old, for COVID-19 immunization; BNT162b2 (Dose Number: 1, Batch/Lot No: EL92676), administration date: 03Mar2021, when the patient was 72-year-old, for COVID-19 immunization. The following information was reported: DIZZINESS (non-serious), DIZZINESS (non-serious) all with onset 11Apr2022 at 16:00, outcome "not recovered" and all described as "light headed & dizzy"; HYPOAESTHESIA ORAL (non-serious), HYPOAESTHESIA ORAL (non-serious) all with onset 14Apr2022, outcome "not recovered" and all described as "Face, tongue & inside mouth numb"; HYPOAESTHESIA (non-serious) with onset 14Apr2022, outcome "not recovered", described as "Numb face/ still numb from nose to chin (nose is less numb)". The events "numb face/ still numb from nose to chin (nose is less numb)", "light headed & dizzy" and "face, tongue & inside mouth numb" required physician office visit. Therapeutic measures were not taken as a result of hypoaesthesia, dizziness, dizziness, hypoaesthesia oral, hypoaesthesia oral.  Additional information- It was reported that Prior to vaccination, the patient was not  diagnosed with COVID-19 and Since the vaccination,  the patient  had not been tested for COVID-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
I gave Boostrix instead of Adacel. Phoned CDC hotline and advised do not repeat dose.
Client states pain at injection site (L Arm) which began 2 days after injection. In addition he reports pain in the L foot , "second and third toes and ball of the foot". Pain comes and goes. States his primary care doctor feels it is probably gout.
This spontaneous report as received from a pharmacy technician refers to a currently 18 year old patient of unknown gender. Information regarding relevant medical history and concurrent condition were not reported. On an unknown date the patient was vaccinated with improperly stored VARIVAX (lot # L049535, expiration date 08-DEC-2017, subcutaneous, dose not reported). The patient was concomitantly used unspecified diluent (manufacturer unknown) (lot # reported as L03598, expiration date 01-MAY-2018). It was reported that the vaccine was exposed to -3 C for 13 hours and 8 minutes. There was no previous excursion. The call was placed because of data logger. It was also reported that on an unknown date, the patient was vaccinated with another dose of VARIVAX (lot # reported as L77777, expiration date January 2017, subcutaneous, dose not reported). This is one of several reports received from the same source. Additional information has been requested.
Major swelling under left underarm and left breast; Major swelling under left underarm and left breast; Booster; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received third booster dose BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 30145BA) via an unspecified route of administration in the left arm on 08Oct2021 at 18:00 (at the age of 31-year-old), as a single dose for COVID-19 immunisation. Medical history included allergies to penicillin and sulfa antibiotics. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ENG6202) via an unspecified route of administration in the left arm on 03Mar2021 at 12:30 (at the age of 30-year-old) and received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8727) via an unspecified route of administration in the left arm on 24Mar2021 at 12:30 (at the age of 30-year-old), both as a single dose for COVID-19 immunisation. On 09Oct2021 at 06:00, the patient experienced major swelling under left underarm and left breast. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19.  The clinical outcome of the event major swelling under left underarm and left breast was not resolved at the time of this report.
Four days after receiving the vaccine I woke up early in the morning to a loud ringing in my left ear that made it hard to hear and made loud sounds more uncomfortable than usual.  The ringing remained all day but did become a little less noticeable toward evening.  By the next morning (Wednesday) the ringing was very quiet and did not affect my hearing very much.  However, the ringing came back to being very loud and made my hearing muffled on Thursday.  Again, it improved on Friday and returned Saturday.  It has followed this pattern ever since.  It never completely goes away but does get better and worse.
This spontaneous report has been received from a 63 year old female registered nurse, reporting on herself with no concurrent conditions, allergies, drug reactions or pertinent medical history reported. There were no concomitant medications. On 06-NOV-2016 the patient was vaccinated with PNEUMOVAX 23 in the arm (dose, frequency, route of administration, lot number and expiration date were not provided) for vaccination. On 06-NOV-2016 (reported as 5 hours later), the patient experienced  in the arm where was given the vaccine of PNEUMOVAX 23 that the whole arm was numb (hypoesthesia) and could not move it (vaccination site movement impairment). The reporter states that the adverse events lasted an hour. No laboratories were performed; the patient monitored by herself the symptoms and did no sought medical attention. At the time of the reporting, the outcome of hypoesthesia and vaccination site movement impairment was reported as recovered. The causal relationship between the hypoesthesia and vaccination site movement impairment and the therapy with PNEUMOVAX 23 was not assessed.
Pt. had seizures - four of them lasting 15-20 min. each. Has had tx with pediatric neurologist - focal seizures.
Injection site started to be painful around 3 PM same day of injection, around 6 PM that same evening of January 28 I began to feel really cool.... went to bed around 730 and throughout the evening I woke up about every 1 to 2 hours sweating but feeling cold. My body hurt to touch. Left work early January 29 because I did not feel good. Afternoon of January 29 around 4 PM I noticed some redness approximately an inch and a half below the injection site. Looked like a lump under my skin and it was painful to the touch. I took Benadryl the evening of January 29 and the morning of January 30.,Not sure if the Benadryl is helping. I am keeping an eye on the redness and the lump, if it does not go away I will contact my provider. I do not feel the chills or feverish anymore and I was able to sleep through the night on January 29